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Introduction
Infertility, defined as the inability to conceive after 1 year
of unprotected intercourse, affects 1 in 10 couples in the
United States (Chandra and Stephen 1998). The etiol-
ogies of infertility are diverse. Although many causes,
including inflammatory tubal disease, ovulatory dys-
function, azoospermia, and immotile cilia syndrome, are
well established, the role of other factors, such as en-
dometriosis, uterine fibroids, and varioceles, is sur-
rounded by intense controversy. During initial clinical
appraisals, each partner must be thoroughly evaluated,
both because male and female factors contribute roughly
equally to the etiology and because more than one cause
of infertility may be present. Despite extensive diagnostic
testing, 10% of infertility remains unexplained. These
patients may suffer from subtle defects not identified by
routine evaluation, or they may represent novel causes
of infertility.
It seems likely that a subgroup of couples with unex-
plained infertility will have intrinsic gamete abnormal-
ities preventing normal sperm-oocyte interaction and
fertilization. This presumption is supported by the re-
duced fertility or complete failure of fertilization during
in vitro procedures. Both the maturation of human gam-
etes and the events surrounding in vivo fertilization are
inaccessible to study by current technologies. However,
recent advances in molecular biology and genetics have
provided investigators with the tools to better under-
stand mammalian fertilization. Bymeans of targetedmu-
tagenesis in embryonic stem cells and transgenesis, it is
possible to create mouse lines lacking specific gene prod-
ucts and to analyze the phenotype. Although a signifi-
cant number of mutant mice created by embry-
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onic–stem-cell technology have hypofertility or infer-
tility (Nishimori and Matzuk 1996), this review will fo-
cus only on a subset—those that affect the development
of the female gamete and its surrounding egg coat, the
zona pellucida (fig. 1).
Folliculogenesis
Unlike males, who produce new sperm continuously
throughout their lives, each female has her lifetime com-
plement of germ cells at birth. These “resting” oocytes
and their surrounding layer of squamous granulosa cells
form the primordial follicle. Cohorts of these follicles
are induced to enter a growth phase, which culminates
(after some weeks, depending on species) in meiotic mat-
uration and ovulation. Concomitant with the onset of
granulosa-cell proliferation, the oocyte initiates its own
growth while remaining arrested in the prophase of the
first meiotic division. The nuclear and cytoplasmic vol-
umes enlarge as the diameter of the oocyte increases.
During this initial growth, the zona pellucida is first
observed as extracellular patches, which later coalesce
into a uniform matrix surrounding the oocyte.
In contrast to early folliculogenesis, follicular devel-
opment to the preovulatory stage is gonadotropin de-
pendent and results in the formation of a central cavity,
the antrum. At approximately the same time as the an-
trum forms, the oocyte stops growing and acquires com-
petence to resume meiosis. However, interactions with
follicle cells maintain the oocyte in meiotic arrest until
shortly before ovulation. The surrounding zona pellu-
cida matrix (7 mm thick in the mouse; 15 mm thick in
humans) physically separates the oocyte and granulosa
cells, but close associations are maintained throughout
follicular development, via paracrine factors and cellular
processes that penetrate the zona to form gap junctions.
In the late stages of folliculogenesis, a surge of luteinizing
hormone (LH) triggers disappearance of the gap junc-
tions and releases the oocyte from meiotic arrest, for
completion of the first meiotic division. The cumulus
oophorus, in whose center lies a mature egg ready for
fertilization, expands and is released during ovulation.
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Figure 1 Genetic mutations affecting female fertility. During human gestation, millions of female germ cells are formed, but only
200–400,000 persist at menarche, and !500 are ovulated prior to menopause. Throughout a women’s reproductive life, multiple follicles enter
a growth phase as a cohort, but only one becomes the dominant Graafian follicle and available for fertilization. A, Germ-cell proliferation and
apoptosis during gestation. B, Folliculogenesis during which oocytes grow and complete the first meiotic division while interacting with the
surrounding follicular cells. C, Sperm-egg interactions at fertilization.
Proliferation and Atresia
The vast majority of growing and nongrowing follicles
are lost by atresia. In humans, this process is particularly
rapid during the neonatal period, when the total oocyte
endowment declines from 6 million at 20 wk gestation
to 1–2 million at birth (Erickson 1986). As in other cases
of programmed cell death, two genes, bcl-2 and bax, are
emerging as important players in this developmental
process. It is currently believed that bcl-2 is a death-
repressor protein, whereas bax is important in the cell-
death pathway. Female mice deficient for bcl-2 are fertile
but have a marked reduction in the number of primor-
dial follicles, compared with those in normal controls
(Ratts et al. 1995). In addition, a number of primordial
follicles are aberrantly formed or contain degenerating
oocytes, although follicles that successfully enter the
growth phase appear normal. The heterogeneity of the
phenotype may reflect the complexity of interactions of
multiple factors (e.g., gonadotropins, ovarian steroids,
and growth factors) that operate in concert to determine
the fate of the oocyte and follicle. In contrast to the bcl-
2-mutant mice, bax-deficient mice are endowed with an
increased number of primordial follicles, compared with
those in normal controls (Tilly 1996), suggesting that
bax and bcl-2 have antagonistic roles. The balance be-
tween germ-cell survival and apoptosis plays an impor-
tant role in reproductive capacity, by determining the
number of oocytes that are available during the repro-
ductive years. A more rapid loss of oocytes from an
environment favoring apoptosis may result in dimin-
ished ovarian reserve and may present, clinically, with
infertility and an early age at menopause.
Gonadotropin-Independent Growth
After birth, the initial stages of folliculogenesis are
gonadotropin independent and are thought to involve
intraovarian growth factors (Kol and Adashi 1995).
Growth-differentiation factor-9 (GDF-9), a member of
the transforming growth-factor-b superfamily, is oocyte
specific. GDF-9 mRNA is first expressed at the primary-
follicle stage and persists even after ovulation. Female
mice carrying a homozygous null mutation for gdf9 are
infertile (Dong et al. 1996). Their ovaries are small on
gross anatomical examination, and follicular develop-
ment does not progress past the primary-follicle stage.
Some aspects of oogenesis, including growth and for-
mation of a zona pellucida, proceed normally; however,
organelle structures are missing or altered, and meiotic
competence is impaired. These abnormalities may reflect
arrested development of the surrounding somatic cells,
reflecting the control that oocytes, by regulating their
microenvironment, exert over their destiny. Gonadotro-
pin levels are elevated in these mice, consistent with
ovarian failure, and, thus, a deficiency in GDF-9 (or
other oocyte-specific growth factors) may lead to pre-
mature ovarian failure.
Gonadotropin-Dependent Growth
The gonadotropins—follicle-stimulating hormone
(FSH) and LH—are secreted from the anterior pituitary,
in response to gonadotropin-releasing hormone
(GnRH). Both the production of ovarian steroids and
normal follicular maturation involve the coordinated ef-
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forts of FSH and LH. The “two-cell hypothesis” of es-
trogen production proposes that LH stimulates theca
cells at the periphery of the growing follicle, to produce
androgens that are then converted (under the influence
of FSH) to estrogens, in the granulosa cells closer to the
oocyte. During the luteal-follicular transition, there is a
rise in FSH, which is necessary for the recruitment of a
cohort of antral follicles. In mice, multiple follicles grow
and ovulate eggs, whereas, in primates, usually one fol-
licle achieves dominance and proceeds to ovulation
while the others become atretic. Although this selection
process is incompletely understood, FSH plays a central
role by establishing an estrogenic microenvironment in
the dominant follicle. As peripheral estradiol levels in-
crease, FSH is lowered by a negative-feedback loop; and
the less competent follicles cannot survive in a state of
relative FSH deficiency.
Gonadotropins are heterodimeric hormones that
share a common a subunit but have distinct b subunits.
Because the release of FSH and LH are under similar
control, it is difficult to distinguish the role of each in-
dependently of the other. Recently, an isolated FSH de-
ficiency was created in mice by a targeted mutation in
the b subunit of fsh (Kumar et al. 1997). Females ho-
mozygous for the mutation are infertile. Their small ova-
ries contain neither antral-stage follicles nor corpora lu-
tea, indicating that these animals fail to ovulate. The
infertile phenotype is reversed by exogenous gonadotro-
pins and confirms the critical role of FSH beyond the
secondary stage of follicular maturation. In humans,
spontaneous mutations of FSH and its receptor have
been reported. A 15-year-old female who is a compound
heterozygote, carrying two mutations in exon 3 of the
FSHb gene, displayed primary amenorrhea and delayed
puberty (Layman et al. 1997). Unaffected family mem-
bers were heterozygous and possessed one copy of the
mutant allele as well as a normal allele. Similar clinical
characteristics were reported in a woman with a ho-
mozygous frameshift mutation identical to one of the
mutations found in the patient described above. This
woman conceived after exogenous FSH was adminis-
tered, demonstrating the same phenotype reversibility
observed in the mouse model (Matthews et al. 1993).
The actions of FSH and LH are mediated by specific
G-protein–coupled receptors. Although the LH recep-
tors are found on both granulosa and thecal cells, the
expression of FSH receptors is restricted to the granulosa
cells. An inactivating mutation of the FSH receptor re-
sults in hypergonadotropic ovarian failure, and such a
mutation may be responsible for a subgroup of women
with normal karyotypes but premature ovarian failure.
In a Finnish population, a recessively inherited, inacti-
vating 566CrT mutation in the FSH receptor gene has
been reported in six families and has been designated
the “FSH resistant ovaries” (FSHRO) syndrome (Ait-
tomaki et al. 1995). Most females with FSHRO are es-
trogen deficient and have hypoplastic ovaries with no
antral follicles. Recently, an inactivating mutation in the
LH receptor was reported in a young woman who pre-
sented with primary amenorrhea and infertility (Toledo
et al. 1996). Ovarian histology revealed normal stages
of follicular development but no corpora lutea or cor-
pora albicans. This supports the notion that FSH is suf-
ficient for follicular development but that LH is crucial
for ovulation. Long-standing hypoestrogenism in this
same individual, indicated by her small uterine size, thin
vaginal walls, and reduced bone mass, is consistent with
the two-cell hypothesis of estrogen production, in which
LH is necessary for the production of androgens, which
are then converted to estrogens in the granulosa cells,
under the influence of FSH.
Ovulation and Fertilization
During most of folliculogenesis, the oocyte is held in
meiotic arrest and does not complete the first meiotic
division until just prior to ovulation. After ovulation,
the residual follicle is transformed into a corpus luteum.
Gap junctions formed between granulosa cells and oo-
cytes have been implicated in the maintenance of meiotic
arrest. Connexins, a class of proteins that directly con-
nect adjacent cells, are an integral component of gap
junctions, and connexin37 participates in the gap junc-
tions formed between granulosa cells and the oocyte.
Female mice carrying a homozygous mutation in the
connexin37 gene (cx37) are infertile, and follicular de-
velopment is arrested at the early antral stage (Simon et
al. 1997). Although premature resumption of meiosis is
not observed in mice lacking connexin37, premature lu-
teinization is detected, which suggests that oocyte signals
are important in the inhibition of these changes and in
the control of the formation of the corpus luteum. This
model supports the importance of two-way communi-
cation between the granulosa cells and the oocyte, in
coordinating the process of folliculogenesis (Eppig et al.
1997). Many features of this phenotype are similar to
those observed in women with a normal karyotype and
premature ovarian failure.
Fertilization occurs in the ampulla of the oviduct,
where acrosome-intact sperm pass through the envel-
oping cumulus oophorus (composed of a glycosamino-
glycan matrix and cumulus cells) and contact the ovu-
lated egg. The binding of sperm to the zona pellucida
induces the acrosome reaction, a sudden release of stored
lytic enzymes. These enzymes may modify the sperm
surface proteins, or they may degrade the zona pellucida
and allow sperm to reach the plasma membrane. After
zona penetration, the acrosome-reacted sperm fuseswith
the egg’s plasma membrane, enters the cytoplasm, and
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“Humanizing” the Mouse Egg Coat
The zona pellucida is a specialized extracellular matrix that
surrounds each ovulated egg. It consists of three major glyco-
proteins that are unique to the zona and that are expressed in
all mammals. Despite this simple structure, the roles of the zona
are complex: it serves in the initial binding of sperm to the egg,
it initiates the acrosome reaction in bound sperm, and it is
modified rapidly after the gametes fuse, to prevent fertilization
by more than one sperm. The molecular basis of each step
remains a matter of active research (Snell and White 1996), but
investigators have begun to tease them apart, using transgenesis.
Female mice that carry an insertional mutation in the Zp3 gene
(moZp3 null) express ZP1 and ZP2 but not ZP3 (Liu et al.
1996; Rankin et al. 1996). Such animals fail to assemble a zona
matrix and are infertile. Recently, we have created transgenic
mouse lines (huZP3) that express human ZP3 in their growing
oocyte (Rankin et al., in press). The human protein expressed
in mouse eggs is posttranslationally modified and incorporated
into the zona matrix as a glycoprotein that is similar to, if not
identical to, native human ZP3.
Taking advantage of the observation that human sperm will
not bind to mouse eggs (Bedford 1977), we have crossed huZP3
mice with moZp3 null mice to produce huZP3 strains, whose
chimeric zonae pellucidae contain mouse ZP1 and ZP2 but
human ZP3. Despite the presence of human ZP3 in these zonae,
human sperm do not bind to huZP3 rescue eggs. Also, not-
withstanding the absence of mouse ZP3, mouse sperm bind and
fertilize the eggs. A simple genetic explanation of these results
is that, if a single human zona protein is required for human
sperm binding, it is probably not human ZP3. However, the
specificity of sperm binding might be determined not by the
protein but by either its posttranslational modifications (which
would be consistent with prevailing paradigms for mouse fer-
tilization) or by the arrangement of the zona proteins in some
characteristic supramolecular structure. We have also created
null mutations in the Zp1 and Zp2 genes, which should allow
us to probe the function of the human homologues in a similar
fashion. If more than one zona protein is required for sperm
binding, simple crosses can produce mouse lines with zonae
pellucidae containing combinations of two or, eventually, all
three human zona proteins, to create a partially or fully “hu-
manized” zona pellucida. These transgenic mouse lines may be
useful not only in determining the molecular basis of human
sperm binding but also as diagnostic reagents for investigating
the causes of infertility in human couples. (Figure adapted from
Castle and Dean 1996.)
forms the male pronucleus of the one-cell zygote. This
sperm-egg fusion induces the cortical granules, located
at the periphery of the egg, to fuse with the egg plasma
membrane and to release their contents into the peri-
vitelline space, modifying the zona so that it no longer
permits subsequent sperm binding or penetration. Thus,
the zona plays a key role in the relatively species-specific
events of fertilization and the postfertilization block to
polyspermy (Yanagimachi 1994).
Formation of the Zona Pellucida
In mice and humans, the zona pellucida is composed
of three sulfated glycoproteins (ZP1, ZP2, and ZP3), the
primary amino acid sequences of which were initially
deduced from cDNA. Of the three zona proteins, mouse
and human ZP3 are the most conserved, each having
polypeptide chains of 424 amino acids, 67% of which
are identical (77% are similar). Mouse and human ZP2
contain 713 and 745 amino acids, respectively, 61% of
which are identical, whereas mouse ZP1 (623 amino
acids) contains 83 additional amino acids, compared
with the human homologue (540 amino acids), and,
when aligned, only 43% of the amino acids are identical.
Each zona protein is posttranslationally modified, and
the apparent masses of the glycoproteins that participate
in the insoluble zona matrix are quite different between
the two species.
The specificity of sperm binding to heterologous zonae
pellucidae differs among mammals, and the role of in-
dividual zona proteins in the mediation of sperm binding
in vitro has been variously described (see sidebar). Pu-
rified mouse ZP3 inhibits sperm binding to the zona
pellucida and induces the sperm acrosome reaction, a
prerequisite to zona penetration.Mouse ZP2 is proposed
to be a secondary sperm receptor, binding to acrosome-
reacted sperm, and a current model suggests that ZP1
plays a structural role by cross-linking filaments com-
posed of ZP2/ZP3 heterodimers (Wassarman 1988). Al-
though no direct evidence exists for human ZP3 acting
as the primary sperm receptor, such a function has been
inferred from its high degree of homology with mouse
ZP3. In other species (i.e., pig and rabbit), homologues
of ZP1 also have been implicated in the mediation of
sperm binding to eggs; and data in a report indicate that
gp69/64 (a homologue of ZP2) is responsible for sperm
binding in Xenopus laevis (Tian et al. 1997).
Targeted disruption of individual zona genes in the
mouse can provide additional insight into the roles of
the zona pellucida in folliculogenesis, fertilization, and
early development. For example, females that carry a
null mutation of ZP3 possess no visible zonae pellucidae
and are infertile (Liu et al. 1996; Rankin et al. 1996).
Analyses of the ovaries from these mice indicate that
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early folliculogenesis proceeds normally but that, as fol-
licles enter the antral phase, many are lost (J. Eppig and
T. Rankin, unpublished observations). Those follicles
that do progress to preovulatory stages contain disor-
ganized cumulus-oocyte complexes, and, in extreme
cases, oocytes are no longer associated with the cumulus
cells in the preovulatory antrum (Rankin et al. 1996).
However, ovulation does occur in these animals, al-
though few eggs are retrieved from the oviducts. The
combination of oocyte loss after the antral-follicular
stage and the virtual absence of eggs in the oviducts after
ovulation likely accounts for the infertility of these mice.
Even if fertilized in vivo, zona-free embryos cannot pass
down the oviduct, presumably because of adhesion to
the lining epithelial cells. This striking phenotype of
zona-free eggs has not been reported in humans, despite
the fact that eggs from hundreds of thousands of infertile
women have been retrieved since the first in vitro fer-
tilization resulting in a live human birth (Steptoe and
Edwards 1978).
Conclusion
Folliculogenesis is a highly orchestrated series of
events that result in the ovulation of an egg ready for
fertilization. The use of targeted mutagenesis has pro-
vided insights into normal follicular physiology, and the
creation of mouse models for human disease has en-
hanced our understanding of these disorders. These an-
imal models provide the means to test the safety and
efficacy of various treatment options, including, poten-
tially, gene therapy. One can envision that slowing or
halting the rate of follicular depletion through genetic
manipulation may improve the reproductive potential of
women who are either at risk for premature ovarian
failure or undergoing cancer treatment with cytotoxic
agents. In addition, both the establishment of model sys-
tems through the use of targeted mutagenesis and other
advances in molecular biology will continue to help de-
cipher the link between genetics and many reproductive
diseases that have eluded diagnosis.
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